Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and Anti-CD154 monoclonal antibody

Diabetes

Volumn 47, Issue 8, 1998, Pages 1199-1206

  Gordon, Ethel J ^a   Markees, Thomas G ^a   Phillips, Nancy E ^a   Noelle, Randolph J ^b   Shultz, Leonard D ^c   Mordes, John P ^a   Rossini, Aldo A ^a,d   Greiner, Dale L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c JACKSON LABORATORY   (United States)

^d Biotech 2 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; GRAFT REJECTION; GRAFT SURVIVAL; HELPER CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; SCID MOUSE; SKIN GRAFT; SPLEEN CELL; XENOGRAFT;

EID: 0031818893     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.8.1199     Document Type: Article

References (40)

1. Harris MI: Classification, diagnostic criteria, and screening for diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Bethesda, MD, National Institutes of Health, 1995, p. 15-36
2. Committee on Xenograft Transplantation: Ethical Issues and Public Policy: Xenotransplantation: Science, Ethics, and Public Policy. Washington, DC, National Academy Press, 1996, p. 1-126
3. Hering BJ: Islet xenotransplantation. In Pancreatic Islet Cell Transplantation: 1892-1992: One Century of Transplantation for Diabetes. Ricordi C, Ed. Austin, TX, R.G. Landes, 1992, p. 313-335
4. Platt JL: Xenotransplantation: recent progress and current perspectives. Curr Opinion Immunol 8:721-728, 1996
5. Lu CY, Khair-el-Din TA, Dawidson IA, Butler TM, Brasky KM, Vazquez MA, Sicher SC: Xenotransplantation. FASEB 78:1122-1130, 1994
6. Bach FH, Winkler H, Wrighton CJ, Robson SC, Stuhlmeier K, Ferran C: Xenotransplantation: a possible solution to the shortage of donor organs. Transplant Proc 28:416-417, 1996
7. Sykes M: Immunobiology of transplantation. FASEB J 10:721-730, 1996
8. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom C, Andersson A: Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:1402-1404, 1994
9. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H: "Infectious" transplantation tolerance. Science 259:974-977, 1993
10. Trucco M, Stassi G: Transplantation biology: educating effector T cells. Nature 380:284-285, 1996
11. Sachs DH: Specific transplantation tolerance. N Engl J Med 325:1240-1242, 1991
12. Faustman D: Strategies for circumventing transplant rejection: modification of cells, tissues and organs. Trends Biotechnol 13:100-105, 1995
13. Simeonovic CJ, Wilson JD: Islets and tolerance. In Pancreatic Islet Cell Transplantation: 1892-1992: One Century of Transplantation for Diabetes. Ricordi C, Ed. Austin, TX, R.G. Landes, 1992, p. 383-393
14. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789-792, 1992
15. GOSS JA, Flye MW, Lacy PE: Induction of allogeneic islet survival by intrahepatic islet preimmunization and transient immunosuppression. Diabetes 45:144-147, 1996
16. Tuch BE, Beretov J, Mandel TE, Koulmanda M: Effect of anti-CD4 monoclonal antibody on survival of xenografted human fetal pancreas. Transplant Proc 27:2183-2184, 1995
17. Mandel TE, Koulmanda M: Effect of anti-CD4 and anti-CD8 monoclonal antibody treatment on fetal pig pancreas xenograft survival in nonobese diabetic/Lt female mice. Transplant Proc 24:216-217, 1992
18. Koulmanda M, Mandel TE: Effect of anti-CD4 and anti-ICAM MAb on survival of fetal pig pancreas grafts in NOD mice. Transplant Proc 26:3466, 1994
19. Mayo GL, Posselt AM, Barker CF, Rostami S, Mayo SP, Campos L, Naji A: Prolongation of survival of donor-strain islet xenografts (rat → mouse) by intrathymic inoculation of xenogeneic islet and bone marrow cells. Transplantation 58:107-109, 1994
20. Ildstad ST, Wren DM, Boggs SS, Hronakes ML, Vecchini F, Van den Brink MRM: Cross-species bone marrow transplantation: evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat to mouse). J Exp Med 174:467-478, 1991
21. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, Noelle RJ, Mordes JP, Rossini AA Survival of mouse pancreatic Islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A 92:9560-9564, 1995
22. Rossini AA, Parker DC, Phillips NE, Durie FH, Noelle RJ, Mordes JR Greiner DL: Induction of immimological tolerance to islet grafts. Cell Transplantation 5:49-52, 1996
23. Markees TG, Phillips NE, Noelle RJ, Shultz LD, Mordes JP, Greiner DL, Rossini AA: Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 64:329-335, 1997
24. Markees TG, Appel MC, Noelle RJ, Mordes JP, Greiner DL, Rossini AA: Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation. Transplant Proc 28:814-815, 1996
25. + cells in the rat. Am J Pathol 148:2043-2056, 1996
26. Zadeh HH, Greiner DL, Wu DY, Tausche F, Goldschneider I: Abnormalities in the export and fate of recent thymic emigrants in diabetes-prone BB/W rats. Autoimmunity 24:35-46, 1996
27. Gottlieb PA, Berrios JP, Mariani G, Handler ES, Greiner D, Mordes JP, Rossini AA: Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes 39:643-645, 1990
28. Billingham R, Medawar P: The technique of free skin grafting in mammals. J Exp Biol 28:385-390, 1951
29. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A 89:6550-6554, 1992
30. Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ: In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 178:1567-1575, 1993
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assn 53:457-481, 1958
32. Matthews DE, Farewell VT: The log-rank or Mantel-Haenszel test for the comparison of survival curves. In Using find Understanding Medical Statistics. 2nd ed. Matthews DE, Farewell VT, Eds. Basel, Karger, 1988, p. 79-87
33. + T cells, interferon-gamma, and CTLA4. J Clin Invest 101:2446-2455, 1998
34. GOSS JA, Nakafusa Y, Finke EH, Flye MW, Lacy PE: Induction of tolerance to islet xenografts in a concordant rat-to-mouse model. Diabetes 43:16-23, 1994
35. Gill RG: The immunobiology of pancreatic islet transplantation. In Type I Diabetes: Molecular, Cellular, and Clinical Immunology. Eisenbarth GS, Lafferty KJ, Eds. Oxford, U.K., Oxford University Press, 1996, p. 118-133
36. Lafferty KJ: Islet cell transplantation as a therapy for type I diabetes mellitus. Diab Nutr Metab 2:323-332, 1989
37. Calcinaro F, Lafferty KJ, Shehadeh NN: Inflammatory mediators and development of autoimmune diabetes. In Type I Diabetes: Molecular, Cellular, and Clinical Immunology. Eisenbarth GS, Lafferty KJ, Eds. Oxford, U.K., Oxford Univeristy Press, 1996, p. 91-117
38. Morris CF, Simeonovic CJ, Fung MC, Wilson JD, Hapel AJ: Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol 154:2470-2482, 1995
39. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:431:3-4321, 1992
40. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ: Immune regulation by CD40 and its ligand gp39. Ann Rev Immunol 14:591-617, 1996